Racis, M.; Sobiczewski, W.; Stanisławska-Sachadyn, A.; Wirtwein, M.; Bluj, E.; Nedoszytko, M.; Borzyszkowska, J.; Limon, J.; Rynkiewicz, A.; Gruchała, M.
NADPH Oxidase Gene Polymorphism is Associated with Mortality and Cardiovascular Events in 7-Year Follow-Up. J. Clin. Med. 2020, 9, 1475.
https://doi.org/10.3390/jcm9051475
AMA Style
Racis M, Sobiczewski W, Stanisławska-Sachadyn A, Wirtwein M, Bluj E, Nedoszytko M, Borzyszkowska J, Limon J, Rynkiewicz A, Gruchała M.
NADPH Oxidase Gene Polymorphism is Associated with Mortality and Cardiovascular Events in 7-Year Follow-Up. Journal of Clinical Medicine. 2020; 9(5):1475.
https://doi.org/10.3390/jcm9051475
Chicago/Turabian Style
Racis, Milena, Wojciech Sobiczewski, Anna Stanisławska-Sachadyn, Marcin Wirtwein, Elżbieta Bluj, Michał Nedoszytko, Joanna Borzyszkowska, Janusz Limon, Andrzej Rynkiewicz, and Marcin Gruchała.
2020. "NADPH Oxidase Gene Polymorphism is Associated with Mortality and Cardiovascular Events in 7-Year Follow-Up" Journal of Clinical Medicine 9, no. 5: 1475.
https://doi.org/10.3390/jcm9051475
APA Style
Racis, M., Sobiczewski, W., Stanisławska-Sachadyn, A., Wirtwein, M., Bluj, E., Nedoszytko, M., Borzyszkowska, J., Limon, J., Rynkiewicz, A., & Gruchała, M.
(2020). NADPH Oxidase Gene Polymorphism is Associated with Mortality and Cardiovascular Events in 7-Year Follow-Up. Journal of Clinical Medicine, 9(5), 1475.
https://doi.org/10.3390/jcm9051475